GENZYME - SUCCESS THROUGH DIVERSITY

Citation
Sm. Thomas et Jf. Burke, GENZYME - SUCCESS THROUGH DIVERSITY, Expert opinion on therapeutic patents, 7(2), 1997, pp. 103-109
Citations number
4
Categorie Soggetti
Medicine, Legal","Pharmacology & Pharmacy
ISSN journal
13543776
Volume
7
Issue
2
Year of publication
1997
Pages
103 - 109
Database
ISI
SICI code
1354-3776(1997)7:2<103:G-STD>2.0.ZU;2-Q
Abstract
Genzyme, the US biotechnology company, has a remarkably broad product base in contrast to similar corporations which have more focused portf olios. In biotechnology, a company's value is based largely upon its p atent portfolio. In the case of Genzyme, the Company's leading product Ceredase (recombinant glucocerebrosidase), is manufactured under lice nce. Substantial income streams are produced from the manufacture of p harmaceuticals and diagnostic reagents. Of particular note are Genzyme 's tissue repair products which combine membrane and recombinant DNA t echnologies.